Advisors Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Sell |
24,300
-413
| -2% | -$193K | 0.18% | 132 |
|
|
2025
Q4 | $11.2M | Sell |
24,713
-1,213
| -5% | -$523K | 0.19% | 112 |
|
|
2025
Q3 | $10.2M | Buy |
25,926
+841
| +3% | +$351K | 0.17% | 130 |
|
|
2025
Q2 | $11.2M | Sell |
25,085
-2,659
| -10% | -$1.23M | 0.2% | 109 |
|
|
2025
Q1 | $13.5M | Buy |
27,744
+132
| +0.5% | +$61.5K | 0.25% | 70 |
|
|
2024
Q4 | $11.1M | Buy |
27,612
+1,145
| +4% | +$531K | 0.2% | 103 |
|
|
2024
Q3 | $12.3M | Buy |
26,467
+3,359
| +15% | +$1.61M | 0.23% | 88 |
|
|
2024
Q2 | $10.8M | Buy |
23,108
+1,724
| +8% | +$748K | 0.21% | 102 |
|
|
2024
Q1 | $8.94M | Buy |
21,384
+3,656
| +21% | +$1.55M | 0.17% | 138 |
|
|
2023
Q4 | $7.21M | Buy |
17,728
+252
| +1% | +$93.1K | 0.15% | 166 |
|
|
2023
Q3 | $6.08M | Buy |
17,476
+1,850
| +12% | +$647K | 0.13% | 186 |
|
|
2023
Q2 | $5.5M | Buy |
15,626
+2,131
| +16% | +$718K | 0.11% | 207 |
|
|
2023
Q1 | $4.25M | Buy |
13,495
+1,709
| +15% | +$513K | 0.09% | 286 |
|
|
2022
Q4 | $3.4M | Sell |
11,786
-413
| -3% | -$126K | 0.07% | 348 |
|
|
2022
Q3 | $3.53M | Buy |
12,199
+1,333
| +12% | +$384K | 0.07% | 308 |
|
|
2022
Q2 | $3.06M | Sell |
10,866
-5,000
| -32% | -$1.34M | 0.06% | 365 |
|
|
2022
Q1 | $4.14M | Sell |
15,866
-5,376
| -25% | -$1.28M | 0.06% | 325 |
|
|
2021
Q4 | $4.67M | Sell |
21,242
-4,458
| -17% | -$867K | 0.07% | 320 |
|
|
2021
Q3 | $4.66M | Sell |
25,700
-1,967
| -7% | -$384K | 0.07% | 279 |
|
|
2021
Q2 | $5.58M | Sell |
27,667
-3,092
| -10% | -$647K | 0.08% | 237 |
|
|
2021
Q1 | $6.61M | Buy |
30,759
+2,604
| +9% | +$572K | 0.1% | 197 |
|
|
2020
Q4 | $6.65M | Buy |
28,155
+3,284
| +13% | +$753K | 0.11% | 173 |
|
|
2020
Q3 | $6.77M | Buy |
24,871
+705
| +3% | +$194K | 0.13% | 150 |
|
|
2020
Q2 | $7.02M | Buy |
24,166
+4,342
| +22% | +$1.18M | 0.14% | 145 |
|
|
2020
Q1 | $4.72M | Buy |
19,824
+2,866
| +17% | +$657K | 0.11% | 178 |
|
|
2019
Q4 | $3.71M | Buy |
16,958
+1,473
| +10% | +$298K | 0.07% | 329 |
|
|
2019
Q3 | $2.62M | Sell |
15,485
-1,022
| -6% | -$181K | 0.05% | 436 |
|
|
2019
Q2 | $3.03M | Sell |
16,507
-3,612
| -18% | -$631K | 0.05% | 406 |
|
|
2019
Q1 | $3.7M | Buy |
20,119
+2,569
| +15% | +$474K | 0.07% | 342 |
|
|
2018
Q4 | $2.91M | Buy |
17,550
+3,458
| +25% | +$599K | 0.06% | 381 |
|
|
2018
Q3 | $2.72M | Sell |
14,092
-1,342
| -9% | -$239K | 0.04% | 478 |
|
|
2018
Q2 | $2.62M | Buy |
15,434
+2,694
| +21% | +$418K | 0.04% | 502 |
|
|
2018
Q1 | $2.12M | Sell |
12,740
-640
| -5% | -$105K | 0.04% | 582 |
|
|
2017
Q4 | $2M | Buy |
13,380
+149
| +1% | +$22.1K | 0.03% | 612 |
|
|
2017
Q3 | $2.01M | Sell |
13,231
-1,762
| -12% | -$265K | 0.03% | 606 |
|
|
2017
Q2 | $1.93M | Sell |
14,993
-850
| -5% | -$102K | 0.03% | 646 |
|
|
2017
Q1 | $1.73M | Sell |
15,843
-12,390
| -44% | -$1.09M | 0.03% | 681 |
|
|
2016
Q4 | $2.08M | Sell |
28,233
-389
| -1% | -$31.7K | 0.03% | 630 |
|
|
2016
Q3 | $2.5M | Sell |
28,622
-6,111
| -18% | -$578K | 0.04% | 555 |
|
|
2016
Q2 | $2.99M | Sell |
34,733
-1,636
| -4% | -$141K | 0.05% | 529 |
|
|
2016
Q1 | $2.89M | Sell |
36,369
-8,642
| -19% | -$782K | 0.05% | 533 |
|
|
2015
Q4 | $5.66M | Sell |
45,011
-1,917
| -4% | -$231K | 0.09% | 319 |
|
|
2015
Q3 | $4.89M | Buy |
46,928
+5,974
| +15% | +$768K | 0.08% | 355 |
|
|
2015
Q2 | $5.06M | Buy |
40,954
+3,743
| +10% | +$472K | 0.07% | 384 |
|
|
2015
Q1 | $4.39M | Buy |
37,211
+9,261
| +33% | +$1.11M | 0.06% | 416 |
|
|
2014
Q4 | $3.32M | Buy |
27,950
+4,906
| +21% | +$553K | 0.04% | 475 |
|
|
2014
Q3 | $2.59M | Buy |
23,044
+9,128
| +66% | +$869K | 0.04% | 523 |
|
|
2014
Q2 | $1.32M | Buy |
13,916
+7,668
| +123% | +$538K | 0.02% | 738 |
|
|
2014
Q1 | $442K | Buy |
6,248
+4,948
| +381% | +$392K | 0.01% | 1045 |
|
|
2013
Q4 | $97K | Buy |
1,300
+100
| +8% | +$6.96K | ﹤0.01% | 1415 |
|
|
2013
Q3 | $91K | Sell |
1,200
-5,800
| -83% | -$462K | ﹤0.01% | 1378 |
|
|
2013
Q2 | $559K | Buy |
+7,000
| New | +$516K | 0.01% | 815 |
|
Other funds holding VRTX
VCM
VPM
Advisors Asset Management's VRTX Position: Q1 2026 in Review
Advisors Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 1.7% in Q1 2026, selling an estimated $193K and leaving 24,300 shares worth $10.9M. The position accounts for 0.18% of the portfolio, ranked #132.
Advisors Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.5M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Advisors Asset Management held 24,300 shares of Vertex Pharmaceuticals worth $10.9M as of Q1 2026.
- Advisors Asset Management sold 413 Vertex Pharmaceuticals shares in Q1 2026, an estimated $193K.
- Vertex Pharmaceuticals made up 0.18% of Advisors Asset Management's portfolio in Q1 2026, its #132 holding.
- Advisors Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's Vertex Pharmaceuticals position peaked at $13.5M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.